German China

Expanded Footprint in the US Acquisition of Chemic Laboratories: Solvias Establishes US Laboratory Presence

Editor: MA Alexander Stark

Independent analytical testing, contract research, development and manufacturing company, Solvias, has acquired Massachusetts-based Chemic Laboratories. With this acquisition, the company gains a strong foothold in the United States and highly complementary laboratory testing capabilities.

Related Vendor

Solvias, one of the largest independent analytical testing, contract research, development and manufacturing companies.
Solvias, one of the largest independent analytical testing, contract research, development and manufacturing companies.
(Source: Solvias)

Kaiseraugst/Switzerland — Located in the biopharmaceutical hub of Boston, Chemic expands Solvias' global presence and portfolio of integrated testing and analytical services. As one organization, Solvias and Chemic:

  • support 650+ pharmaceutical corporations, biotech businesses, emerging ATMP companies, as well as medical device and cosmetics companies;
  • operate nearly 225,000 square feet of laboratory space in Switzerland, France and the United States in accordance with the highest industry standards, including ISO, cGMP and GLP;
  • offer an extensive suite of analytical services including chemical and physical characterization, quality control, microbiology and cell biology testing and stability testing;
  • provide combined areas of strengths in synthesis, catalysis and in extractable and leachable testing;
  • employ more than 600 people possessing deep scientific and technical expertise, with a significant number holding advanced academic degrees.

Chemic is Solvias' first acquisition since partnering with health care investors Water Street Healthcare Partners and JLL Partners in June 2020 to strategically grow the company. Since then, Solvias has recruited industry leaders to join its board and commenced a program to significantly upgrade and expand its information technology platform and infrastructure in support of further global expansion plans. The company is pursuing organic investments and acquisitions to add specialized capabilities to support clients in the growing areas of biologics and cell & gene therapies.

Chemic's co-founders, Messrs. St. Laurent and Goodrich, will join Solvias' leadership team and continue to lead operations in the United States. They also will continue to operate Chemic's product development businesses as separate entities.